603 related articles for article (PubMed ID: 21756229)
21. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.
McMillan SJ; Crocker PR
Carbohydr Res; 2008 Aug; 343(12):2050-6. PubMed ID: 18279844
[TBL] [Abstract][Full Text] [Related]
22. Siglecs, sialic acids and innate immunity.
Crocker PR; Varki A
Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
[TBL] [Abstract][Full Text] [Related]
23. Structural implications of Siglec-5-mediated sialoglycan recognition.
Zhuravleva MA; Trandem K; Sun PD
J Mol Biol; 2008 Jan; 375(2):437-47. PubMed ID: 18022638
[TBL] [Abstract][Full Text] [Related]
24. Siglecs in Brain Function and Neurological Disorders.
Siddiqui SS; Matar R; Merheb M; Hodeify R; Vazhappilly CG; Marton J; Shamsuddin SA; Al Zouabi H
Cells; 2019 Sep; 8(10):. PubMed ID: 31546700
[TBL] [Abstract][Full Text] [Related]
25. Complex of sialoadhesin with a glycopeptide ligand.
Bukrinsky JT; St Hilaire PM; Meldal M; Crocker PR; Henriksen A
Biochim Biophys Acta; 2004 Nov; 1702(2):173-9. PubMed ID: 15488769
[TBL] [Abstract][Full Text] [Related]
26. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
27. [Functions of sialic acids-binding lectins, Siglecs].
Yamaji T; Hashimoto Y
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1098-105. PubMed ID: 12807015
[No Abstract] [Full Text] [Related]
28. Siglecs as targets for therapy in immune-cell-mediated disease.
O'Reilly MK; Paulson JC
Trends Pharmacol Sci; 2009 May; 30(5):240-8. PubMed ID: 19359050
[TBL] [Abstract][Full Text] [Related]
29. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
[TBL] [Abstract][Full Text] [Related]
30. Sialylation of the sialic acid binding lectin sialoadhesin regulates its ability to mediate cell adhesion.
Barnes YC; Skelton TP; Stamenkovic I; Sgroi DC
Blood; 1999 Feb; 93(4):1245-52. PubMed ID: 9949167
[TBL] [Abstract][Full Text] [Related]
31. The structure of siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design.
Attrill H; Takazawa H; Witt S; Kelm S; Isecke R; Brossmer R; Ando T; Ishida H; Kiso M; Crocker PR; van Aalten DM
Biochem J; 2006 Jul; 397(2):271-8. PubMed ID: 16623661
[TBL] [Abstract][Full Text] [Related]
32. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
Angata T; Hingorani R; Varki NM; Varki A
J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
[TBL] [Abstract][Full Text] [Related]
33. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
[TBL] [Abstract][Full Text] [Related]
34. New I-type lectins of the CD 33-related siglec subgroup identified through genomics.
Crocker PR; Zhang J
Biochem Soc Symp; 2002; (69):83-94. PubMed ID: 12655776
[TBL] [Abstract][Full Text] [Related]
35. Evolutionarily conserved paired immunoglobulin-like receptor α (PILRα) domain mediates its interaction with diverse sialylated ligands.
Sun Y; Senger K; Baginski TK; Mazloom A; Chinn Y; Pantua H; Hamidzadeh K; Ramani SR; Luis E; Tom I; Sebrell A; Quinones G; Ma Y; Mukhyala K; Sai T; Ding J; Haley B; Shadnia H; Kapadia SB; Gonzalez LC; Hass PE; Zarrin AA
J Biol Chem; 2012 May; 287(19):15837-50. PubMed ID: 22396535
[TBL] [Abstract][Full Text] [Related]
36. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
Crocker PR
Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
[TBL] [Abstract][Full Text] [Related]
37. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
Nitschke L
Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
[TBL] [Abstract][Full Text] [Related]
38. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily.
Angata T; Varki A
Glycobiology; 2000 Apr; 10(4):431-8. PubMed ID: 10764831
[TBL] [Abstract][Full Text] [Related]
39. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
40. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
